EARS
Altamira Therapeutics Ltd.
Set alert
52-week range unavailable
- Open
- 3.08
- Prev close
- 3.05
- Mkt cap
- 39.19M
- Vol
- 174.07K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 3.00
- High
- 3.09
- Forward P/E
- -0.72
- Beta
- 1.40
- Short ratio
- 0.08
- Inst. own
- 5.58%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Mar 31, 2021
- 50-d avg
- 3.25
- 200-d avg
- 3.41
- 1y target
- 0.00
News
5 years ago globenewswire.com
Auris Medical Announces Launch of New Corporate Website
Hamilton, Bermuda, July 15, 2021 – Auris Medical Holding Ltd. (NASDAQ: EARS), a company dedicated to addressing unmet medical needs through RNA therapeutics, allergy and viral infection protection,…
5 years ago pennystocks.com
5 Reddit Penny Stocks to Watch That Are Moving Right Now
Are these Reddit penny stocks worth adding to your small-caps watchlist right now? The post 5 Reddit Penny Stocks to Watch That Are Moving Right Now appeared first on Penny Stocks to Buy, Picks, News…
5 years ago benzinga.com
Auris Medical's Bentrio Nasal Spray Shows Encouraging Preclinical Action In Prevention, Mitigation Of COVID-19
Auris Medical Holding Ltd (NASDAQ: EARS) has announced additional preclinical data in a primary human nasal airway epithelium model from its Bentrio (AM-301) nasal spray for COVID-19. AM-301 was…
5 years ago globenewswire.com
Auris Medical Announces Publication of Data from Preclinical Studies with Bentrio™ Nasal Spray in Prevention and Mitigation of SARS-CoV-2
Hamilton, Bermuda, July 14, 2021 – Auris Medical Holding Ltd. (NASDAQ: EARS), a company dedicated to addressing unmet medical needs through RNA therapeutics, allergy and viral infection protection,…
5 years ago globenewswire.com
Auris Medical to Initiate Market Launch of Bentrio™ Nasal Spray in Germany
Hamilton, Bermuda, June 28, 2021 – Auris Medical Holding Ltd. (NASDAQ: EARS), a company dedicated to addressing unmet medical needs through RNA therapeutics, allergy and viral infection protection,…
5 years ago pulse2.com
EARS Stock Price Increases Over 14% Pre-Market
The stock price of Auris Medical Holding Ltd. (NASDAQ: EARS) increased by over 14% pre-market.
5 years ago benzinga.com
Auris Medical Enters RNA Therapeutics with Trasir Therapeutics Acquisition; Plans To Spin-Off/Divest Existing Programs
Auris Medical Holding Ltd (NASDAQ: EARS) has acquired privately-held Trasir Therapeutics Inc, focused on extrahepatic oligonucleotide delivery. The purchase price comprises 0.77 million common…
5 years ago pulse2.com
EARS Stock Price: Over 9% Increase Pre-Market Explanation
The stock price of Auris Medical Holding Ltd (NASDAQ: EARS) increased by over 9% pre-market. This is why it happened.
5 years ago globenewswire.com
Auris Medical Holding to Present at LD Micro Invitational XI Conference
Hamilton, Bermuda, May 28, 2021 – Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology,…
5 years ago globenewswire.com
Auris Medical Reaches Midpoint for Enrollment in Part B of AM-125 Phase 2 TRAVERS Trial in Acute Peripheral Vertigo
Hamilton, Bermuda, May 14, 2021 – Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology,…
5 years ago pennystocks.com
4 Meme Penny Stocks To Watch As DogeCoin Rises
Meme penny stocks are a budding sector; have you heard of these 4? The post 4 Meme Penny Stocks To Watch As DogeCoin Rises appeared first on Penny Stocks to Buy, Picks, News and Information |…
5 years ago benzinga.com
Auris Medical Stock Is Trading Higher As Bentrio Hit Primary Endpoint Goal In Allergic Rhinitis Study
Auris Medical Holding Ltd (NASDAQ: EARS) has announced additional information regarding the results from the clinical trial of its nasal spray, Bentrio, meant for treating people suffering from…
5 years ago pulse2.com
EARS Stock: Over 30% Increase Intraday Explanation
The stock price of Auris Medical Holding Ltd (NASDAQ: EARS) increased by over 30% during intraday trading. This is why it happened.
5 years ago globenewswire.com
Auris Medical Provides Update on Bentrio Program in Allergy
Hamilton, Bermuda, May 7, 2021 – Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology,…
5 years ago globenewswire.com
Auris Medical Announces Positive Preclinical and Clinical Outcomes with AM-301 and Details Plans for Market Launch
Hamilton, Bermuda, April 13, 2021 – Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology,…
5 years ago pulse2.com
EARS Stock: Over 9% Increase Pre-Market Explanation
The stock price of Auris Medical Holding Ltd (NASDAQ: EARS) increased by over 9% pre-market. This is why it happened.
-
5 years ago benzinga.com
44 Biggest Movers From Yesterday
Gainers Chemomab Therapeutics Ltd. (NASDAQ: CMMB) shares jumped 111.5% to close at $55.00 on Thursday.
5 years ago benzinga.com
Why Auris Medical, CytoDyn and Prometheus Shares Are Moving Today
Auris Medical Holding Ltd. (NASDAQ: EARS), CytoDyn Inc. (OTC: CYDY) and Prometheus Biosciences, Inc. (NASDAQ: RXDX) are among the biggest movers in the biopharma space Thursday.
5 years ago pulse2.com
EARS Stock Price Increased Over 4% Pre-Market: Why It Happened
The stock price of Auris Medical Holding Ltd. (NASDAQ: EARS) increased by over 4% pre-market.
5 years ago globenewswire.com
Auris Medical Provides Business Update and Reports Second Half and Full Year 2020 Financial Results
Hamilton, Bermuda, March 31, 2021 – Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology,…
5 years ago pulse2.com
EARS Stock Price Increased 52.05%: Why It Happened
The stock price of Auris Medical Holding Ltd (NASDAQ: EARS) increased by 52.05% yesterday. This is why it happened.
-
5 years ago benzinga.com
38 Stocks Moving in Tuesday's Pre-Market Session
Gainers INVO Bioscience, Inc. (NASDAQ: INVO) shares rose 108.4% to $6.48 in pre-market trading after the company announced an amendment under its exclusive U.S. commercialization agreement with…
-
5 years ago benzinga.com
78 Biggest Movers From Yesterday
Gainers Obalon Therapeutics, Inc. (NASDAQ: OBLN) shares climbed 115% to close at $2.30 on Monday after declining around 5% on Friday.
-
5 years ago benzinga.com
54 Stocks Moving In Monday's Mid-Day Session
Gainers Obalon Therapeutics, Inc. (NASDAQ: OBLN) shares jumped 115.9% to $2.31 after declining around 5% on Friday.
-
5 years ago benzinga.com
Stocks That Hit 52-Week Highs On Tuesday
Tuesday's morning session saw 195 companies set new 52-week highs.
-
6 years ago benzinga.com
Stocks That Hit 52-Week Lows On Thursday
Stocks That Hit 52-Week Lows On Thursday
-
6 years ago benzinga.com
Stocks That Hit 52-Week Lows On Wednesday
Stocks That Hit 52-Week Lows On Wednesday
-
7 years ago benzinga.com
Stocks That Hit 52-Week Lows On Friday
Stocks That Hit 52-Week Lows On Friday
-
8 years ago benzinga.com
Stocks Which Set New 52-Week Low Yesterday, August 15th
Stocks Which Set New 52-Week Low Yesterday, August 15th
-
8 years ago benzinga.com
35 Stocks Moving In Tuesday's Mid-Day Session
35 Stocks Moving In Tuesday's Mid-Day Session